Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1979 May;54(5):362–366. doi: 10.1136/adc.54.5.362

Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy.

L M Drummond
PMCID: PMC1545573  PMID: 475411

Abstract

The PKU sample, if taken after the 3rd day, is suitable for Duchenne muscular dystrophy screening using creatine phosphokinase (CPK) levels. 101 babies (53 girls and 48 boys) had CPK levels measured on filter paper blood specimens taken by heel prick on the 1st and 4th days of life. The method used was that described by Zellweger and Antonik (1975). The CPK levels were markedly raised on the 1st day of life but by the 4th they had reduced to within 3 times the upper limit of the normal range for adults. 10,000 boys were then screened for Duchenne muscular dystrophy using the PKU sample, and 2 cases were found.

Full text

PDF
365

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beckmann R., Scheuerbrandt G., Antonik A. Erfassung von präklinischer Duchenne-Muskeldystrophie beig Neugeborenen mit dem CK-Screening-Test. Monatsschr Kinderheilkd. 1976 Sep;129(9):658–659. [PubMed] [Google Scholar]
  2. Bodensteiner J. B., Zellweger H. Creatine phospholinase in normal neonates and young infants. J Lab Clin Med. 1971 May;77(5):853–858. [PubMed] [Google Scholar]
  3. Demos J. Early diagnosis and treatment of rapidly developing Duchenne De Boulogne type myopathy (type DDB I). Am J Phys Med. 1971 Dec;50(6):271–284. [PubMed] [Google Scholar]
  4. Dubowitz V. Screening for Duchenne muscular dystrophy. Arch Dis Child. 1976 Apr;51(4):249–251. doi: 10.1136/adc.51.4.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Duchenne muscular dystrophy: early diagnosis, and screening. Arch Dis Child. 1976 Dec;51(12):982–986. doi: 10.1136/adc.51.12.982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gilboa N., Swanson J. R. Serum creatine phosphokinase in normal newborns. Arch Dis Child. 1976 Apr;51(4):283–285. doi: 10.1136/adc.51.4.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. MORTON N. E., CHUNG C. S. Formal genetics of muscular dystrophy. Am J Hum Genet. 1959 Dec;11:360–379. [PMC free article] [PubMed] [Google Scholar]
  8. Roses A. D., Nicholson G. A., Roe C. R. Screening for Duchenne muscular dystrophy. Pediatrics. 1977 Aug;60(2):248–251. [PubMed] [Google Scholar]
  9. Rudolph N., Gross R. T. Creatine phosphokinase activity in serum of newborn infants as an indicator of fetal trauma during birth. Pediatrics. 1966 Dec;38(6):1039–1046. [PubMed] [Google Scholar]
  10. Skinner R., Emery A. E., Anderson A. J., Foxall C. The detection of carriers of benign (Becker-type) X-linked muscular dystrophy. J Med Genet. 1975 Jun;12(2):131–134. doi: 10.1136/jmg.12.2.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Zellweger H., Antonik A. Newborn screening for Duchenne muscular dystrophy. Pediatrics. 1975 Jan;55(1):30–34. [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES